Anna Maria Storniolo

  • 11111 Citations
  • 34 h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 20 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
exemestane Medicine & Life Sciences
letrozole Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Hot Flashes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1976 2009

GENERAL CLINICAL RESEARCH CENTER

Wilkes, D., Crabb, D., Rex, D., Einhorn, L., Zipes, D., Benson, M., Moe, S., Abonour, R., Farlow, M., Miller, K., Loehrer, P., Cripe, L., Peacock, M., DiMeglio, L., Econs, M., Spinola, S., de Cordon, K., Denne, S., Kwo, P., Agarwal, R., Considine, R., Poindexter, B., Stevens, J., Kraus, M., Chalasani, N., Robertson, M., Logan, T., Croop, J., Groh, W., Robertson, M., Hannon, T., Wojcieszek, J., Considine, R., Mather, K., Chalasani, N., Flockhart, D. A., Foroud, T., Desta, Z., Benson, M., Kareken, D., Poindexter, B., Friedman, A., Gupta, S., Schneider, B., Carpenter, J., Steiner, S., Storniolo, A. M., Cripe, L., Murphy, M., Molleston, J., Hui, S., Von Ah, D., Logan, T., Sawada, S., Fineberg, S. E., Edmondson, J. W., Lumeng, L., O'Connor, K., Clark, C. M., Maxwell, D., Scott, P., Prystowsky, E., Hoffman, R., Brater, C. D., Brandt, I., Bradley, J., Vinicor, F., Williams, S., Weir, C., Heger, J., Thomasson, H., Manolagas, S., Duckworth, W., MacLaren, N., Mohler, E., Baker, J., Vargo, D., Lehman, G., Einhorm, L., Luft, F., Scheller, C., Rudy, D., Merritt, D. H., Kleit, S., Williams, D., Wheeler, M., Twigg, H., Weinberger, M., Wheat, L. J., Holden, R., Rawl, S., Smith, F. O., Shankar, R., Kirkman, S. U. E., Richardson, J., Pratt, J. H., Rodriguez, H., Hall, S., McDougle, C., Brater, D. C., Dropco, E., Krause, M., Baker, S., Wilensky, R., Hamburger, R., Jakacki, R., Oconnor, S., Rink, R., Biller, J., Prince, M., Klaunig, J., Reed, T. E., Harris, A., Myers, S., Jackson, R., Jindal, R., Haehner, B., Johnston, C. C., Black, J., McCaskill-Steve, W., Clark, C., Roos, K., Batiuk, T., Brady, M., Oconner, S., Keck, J., Brashear, A., Timmerman, R., Goldmna, M., Mohler, E. R., Guare, J., Frank, M., Siemers, E., Dropcho, E. J., Davidson, D., Pompili, V., Patrick Loehrer, M. D., Gumbiner, B., Michael Frank, M. D., Wheat, L. J., O'Connor, S., Dusick, A., Ernst, J., Sowinski, K., Batiuk, T., Rushing, D., Stout, J., Bangs, M., Sokol, G., Lemons, J., Gorski, J. C., Johnson, R., Sweeney, C., Dennis Chua, A., Dube, M., Galinsky, R. E., Steinberg, H., Pescovitz, M. D., Twigg, H., Fife, K. H., O'Connor, S. J., Tisdale, J. E., Vik, T., Govani, M., Gardner, T. W., Blekher, T., Kays, M., Johnston, C., Howenstine, M., Dusick, A., Yaqub, M., Kreher, N., Morris, E., Posey, D., Nebesio, T., Ragg, S., Kowolik, M., Ellett, M., Shankar, S., Walvoord, E., Shore, C., Deeg, M., Matei, D., Tisdale, J. E., Bruno, A., Knox, K., Stout, J., Blekher, T., Saifullah, A., Jin, Y. A. N., Griest, A., Nurnberger, J., Hathaway, D., Voelker, J., Abel, L., Faust, H., Brater, C., Garcia, J. O. E., Garvey, T., Johnston, C. C., Fergusson, J., O'Connor, S., Greist, A., Shapiro, A. M. Y., Eigen, H., Roth, B. J., Pescovitz, O., Lemons, J., Pescovitz, M., Rickard, K., Christian, J., Sokol, G., Bradley, J. D., Steinberg, H., Freidenberg, G., Wheat, J., Fife, K., Gordon, M., Pratt, H., Mannix, E., Sledge, G., Sandler, A., Baron, A., Leitch, C. & Goldman, M.

National Institutes of Health

12/1/7611/30/09

Project: Research project

salmon calcitonin
Haemophilus ducreyi
Amyloidosis
Osteoporotic Fractures
Osteoporosis

Publications 1987 2019

  • 11111 Citations
  • 34 h-Index
  • 103 Article
  • 1 Book
  • 1 Chapter

Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion

Kamdem, L. K., Xi, J., Clark, B. L., Gregory, B. J., Kidwell, K. M., Storniolo, A. M., Stearns, V., Hayes, D. F., Gersch, C. L., Rae, J. M., Henry, N. L. & Hertz, D. L., Jan 1 2019, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

exemestane
letrozole
Gene Deletion
Women's Health
Aromatase Inhibitors
1 Citation (Scopus)

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

Connolly, R. M., Leal, J. P., Solnes, L., Huang, C. Y., Carpenter, A., Gaffney, K., Abramson, V., Carey, L. A., Liu, M. C., Rimawi, M., Specht, J., Storniolo, A. M., Valero, V., Vaklavas, C., Krop, I. E., Winer, E. P., Camp, M., Miller, R. S., Wolff, A. C., Cimino-Mathews, A. & 3 othersPark, B. H., Wahl, R. L. & Stearns, V., Mar 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 9, p. 714-722 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Fluorodeoxyglucose F18
Estrogen Receptors
Area Under Curve
ROC Curve
2 Citations (Scopus)

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

Mosher, C. E., Secinti, E., Li, R., Hirsh, A. T., Bricker, J., Miller, K., Schneider, B., Storniolo, A. M., Mina, L., Newton, E. V., Champion, V. & Johns, S., Jan 12 2018, (Accepted/In press) In : Supportive Care in Cancer. p. 1-12 12 p.

Research output: Contribution to journalArticle

Acceptance and Commitment Therapy
Fatigue
Breast Neoplasms
Sleep
Telephone

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, J. R., Eckhardt, S. G., Pitts, T. M., van Bokhoven, A., Aisner, D., Gustafson, D. L., Capasso, A., Sams, S., Kabos, P., Zolman, K., Colvin, T., Elias, A. D., Storniolo, A. M., Schneider, B., Gao, D., Tentler, J. J., Borges, V. F. & Miller, K., Aug 2 2018, In : Breast Cancer Research. 20, 1, 82.

Research output: Contribution to journalArticle

Aurora Kinases
Triple Negative Breast Neoplasms
Phase II Clinical Trials
Angiogenesis Inhibitors
Microvessels

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Santa-Maria, C. A., Bardia, A., Blackford, A. L., Snyder, C., Connolly, R. M., Fetting, J. H., Hayes, D. F., Jeter, S. C., Miller, R. S., Nguyen, A., Quinlan, K., Rosner, G. L., Slater, S., Storniolo, A. M., Wolff, A. C., Zorzi, J., Henry, N. L. & Stearns, V., May 11 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Aromatase Inhibitors
exemestane
Pharmacogenetics